Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Summary

The purpose of this study is to look at the safety and immune response to a vaccine used in patients previously treated for HER2 (human epidermal growth factor receptor 2) positive breast cancer.

Timeline

Start

2012-07-09

Primary completion

2014-03-24

Completion

2018-07-09

Drugs

Indications